3-imidazolyl-indoles for the treatment of proliferative diseases
The invention relates to 3-heterocyclyl indolyl compounds of formula I capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively: wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KALLEN JORG HERGOVICH LISZTWAN JOANNA VAUPEL ANDREA FURET PASCAL GROELL JEAN-MARC MAYR LORENZ BOETTCHER ANDREAS MASUYA KEIICHI BUSCHMANN NICOLE |
| description | The invention relates to 3-heterocyclyl indolyl compounds of formula I capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively: wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8053457B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8053457B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8053457B23</originalsourceid><addsrcrecordid>eNqNyjEKAjEQBdBtLES9w1wgIMZFy0VR7NV6GcwPDmQzIRkEPb2NB7B6zZt3g3cySeCPpndykoMmNIpayZ4gq2CbkI00UqmaJKKyyQsUpIEb2rKbRU4Nq5-Ljs6n2_HiUHREK_xAho33637d-22_O2z8H-ULjdIxcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-imidazolyl-indoles for the treatment of proliferative diseases</title><source>esp@cenet</source><creator>KALLEN JORG ; HERGOVICH LISZTWAN JOANNA ; VAUPEL ANDREA ; FURET PASCAL ; GROELL JEAN-MARC ; MAYR LORENZ ; BOETTCHER ANDREAS ; MASUYA KEIICHI ; BUSCHMANN NICOLE</creator><creatorcontrib>KALLEN JORG ; HERGOVICH LISZTWAN JOANNA ; VAUPEL ANDREA ; FURET PASCAL ; GROELL JEAN-MARC ; MAYR LORENZ ; BOETTCHER ANDREAS ; MASUYA KEIICHI ; BUSCHMANN NICOLE</creatorcontrib><description>The invention relates to 3-heterocyclyl indolyl compounds of formula I capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively: wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111108&DB=EPODOC&CC=US&NR=8053457B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111108&DB=EPODOC&CC=US&NR=8053457B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KALLEN JORG</creatorcontrib><creatorcontrib>HERGOVICH LISZTWAN JOANNA</creatorcontrib><creatorcontrib>VAUPEL ANDREA</creatorcontrib><creatorcontrib>FURET PASCAL</creatorcontrib><creatorcontrib>GROELL JEAN-MARC</creatorcontrib><creatorcontrib>MAYR LORENZ</creatorcontrib><creatorcontrib>BOETTCHER ANDREAS</creatorcontrib><creatorcontrib>MASUYA KEIICHI</creatorcontrib><creatorcontrib>BUSCHMANN NICOLE</creatorcontrib><title>3-imidazolyl-indoles for the treatment of proliferative diseases</title><description>The invention relates to 3-heterocyclyl indolyl compounds of formula I capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively: wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKAjEQBdBtLES9w1wgIMZFy0VR7NV6GcwPDmQzIRkEPb2NB7B6zZt3g3cySeCPpndykoMmNIpayZ4gq2CbkI00UqmaJKKyyQsUpIEb2rKbRU4Nq5-Ljs6n2_HiUHREK_xAho33637d-22_O2z8H-ULjdIxcA</recordid><startdate>20111108</startdate><enddate>20111108</enddate><creator>KALLEN JORG</creator><creator>HERGOVICH LISZTWAN JOANNA</creator><creator>VAUPEL ANDREA</creator><creator>FURET PASCAL</creator><creator>GROELL JEAN-MARC</creator><creator>MAYR LORENZ</creator><creator>BOETTCHER ANDREAS</creator><creator>MASUYA KEIICHI</creator><creator>BUSCHMANN NICOLE</creator><scope>EVB</scope></search><sort><creationdate>20111108</creationdate><title>3-imidazolyl-indoles for the treatment of proliferative diseases</title><author>KALLEN JORG ; HERGOVICH LISZTWAN JOANNA ; VAUPEL ANDREA ; FURET PASCAL ; GROELL JEAN-MARC ; MAYR LORENZ ; BOETTCHER ANDREAS ; MASUYA KEIICHI ; BUSCHMANN NICOLE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8053457B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KALLEN JORG</creatorcontrib><creatorcontrib>HERGOVICH LISZTWAN JOANNA</creatorcontrib><creatorcontrib>VAUPEL ANDREA</creatorcontrib><creatorcontrib>FURET PASCAL</creatorcontrib><creatorcontrib>GROELL JEAN-MARC</creatorcontrib><creatorcontrib>MAYR LORENZ</creatorcontrib><creatorcontrib>BOETTCHER ANDREAS</creatorcontrib><creatorcontrib>MASUYA KEIICHI</creatorcontrib><creatorcontrib>BUSCHMANN NICOLE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KALLEN JORG</au><au>HERGOVICH LISZTWAN JOANNA</au><au>VAUPEL ANDREA</au><au>FURET PASCAL</au><au>GROELL JEAN-MARC</au><au>MAYR LORENZ</au><au>BOETTCHER ANDREAS</au><au>MASUYA KEIICHI</au><au>BUSCHMANN NICOLE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-imidazolyl-indoles for the treatment of proliferative diseases</title><date>2011-11-08</date><risdate>2011</risdate><abstract>The invention relates to 3-heterocyclyl indolyl compounds of formula I capable of inhibiting the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively: wherein R1, R2, R3, R4, RA, Y and Y are as defined in the specification. Due to their activity, the compounds are useful in the treatment of various disorders and diseases mediated by the activity of MDM2 and/or MDM4, or variants thereof, such as inflammatory or proliferative diseases or in the protection of cells.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8053457B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | 3-imidazolyl-indoles for the treatment of proliferative diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T07%3A54%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KALLEN%20JORG&rft.date=2011-11-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8053457B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |